Safety
Ensures high safety by reducing Gadolinium deposition in the body
Registered
Active Ingredient ‘Gadoterate Meglumine’ registered with US FDA (#36148)
Approved
Approved for use in adults and paediatric population
Availability
Available in vials of 10ml, 15ml & 20ml
European regulatory authority has recommended the use of macrocyclic contrast agents & suspended / restricted use of linear contrast agents since 2017 due to safety concerns
Product | Type | Recommendation |
---|---|---|
Gadobutrol | Macrocyclic | Maintain |
Gadoterate | Macrocyclic | Maintain |
Gadodiamide | Linear | Suspend |
Gadobenate | Linear | Restrict use to liver scans |
Gadopentetate | Linear | Restrict to intra-articular |
Source: https://www.ema.europa.eu/en/medicines/human/referrals/gadolinium-containing-contrast-agents